Liguiritigenin-7-O-D-apiosyl-4-O-D-glucoside
CAS No. 199796-12-8
Liguiritigenin-7-O-D-apiosyl-4-O-D-glucoside( ——— )
Catalog No. M39471 CAS No. 199796-12-8
Liguiritigenin-7-O-D-apiosyl-4'-O-D-glucoside is a flavanone glycoside isolated from Glycyrrhizia inflate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 265 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLiguiritigenin-7-O-D-apiosyl-4-O-D-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionLiguiritigenin-7-O-D-apiosyl-4'-O-D-glucoside is a flavanone glycoside isolated from Glycyrrhizia inflate.
-
DescriptionLiquiritin apioside has antioxidant property by inducing glutathione (GSH) biosynthesis via the inhibition of cytokines and protected lung epithelial cells against cigarette smoke-mediated oxidative stress, might be as protective agent against epithelial injury in COPD.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayApoptosis
-
TargetTNF
-
RecptorTGF-β/Smad;TNF-α
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number199796-12-8
-
Formula Weight550.513
-
Molecular FormulaC26H30O13
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL (181.65 mM; )
-
SMILESOC[C@H]1O[C@@H](Oc2ccc(cc2)[C@@H]2CC(=O)c3ccc(O[C@@H]4OC[C@](O)(CO)[C@H]4O)cc3O2)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang B, et al. Two new flavanone glycosides from Glycyrrhizia inflata. Yao Xue Xue Bao. 1997;32(3):199-202.?
molnova catalog
related products
-
INH1
INH1 is a cell-permeable Hec1 inhibitor that specifically disrupts the Hec1/Nek2 interaction.
-
MALTOTETRAOSE
MALTOTETRAOSE are potent inhibitors of TNF-α-induced intercellular adhesion molecule-1 (ICAM-1) expression maltotetraose may be beneficial in the suppression of early atherosclerosis development.
-
XYLOBIOSE
XYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.
Cart
sales@molnova.com